This inventor holds 1 USPTO granted patent. Top assignee: Apogee Therapeutics, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Innovations of Peter Harwin in Antibody Development
Introduction
Peter Harwin is an accomplished inventor based in Waltham, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibodies that target interleukin 13 (IL-13). His work is crucial for advancing treatments for inflammatory diseases.
Latest Patents
Peter Harwin holds a patent for "Antibodies that bind interleukin 13 and methods of use." This patent describes novel and improved antibodies that bind IL-13 and outlines methods for inhibiting its biological activity. The patent also details pharmaceutical compositions that include these anti-IL-13 antibodies, which are intended for the treatment of inflammatory diseases associated with elevated levels of IL-13 and/or IgE.
Career Highlights
Harwin is currently associated with Apogee Therapeutics, Inc., where he continues to innovate in the field of therapeutic antibodies. His expertise in antibody development has positioned him as a key figure in the biotechnology sector.
Collaborations
Throughout his career, Peter has collaborated with notable professionals, including Hussam H Shaheen and Kenneth Evan Thompson. These collaborations have further enhanced the impact of his work in the field.
Conclusion
Peter Harwin's contributions to antibody development represent a significant advancement in the treatment of inflammatory diseases. His innovative work continues to pave the way for new therapeutic options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile